Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Recurrence 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Transanal Endoscopic Surgery × Clear all
NCT03959839 2025-06-03

DSETAMIS2018

Puerta de Hierro University Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT01340755 2017-09-06

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Massachusetts General Hospital

Phase NA Completed
5 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02626728 2016-11-22

TAMIS

Hvidovre University Hospital

Completed
25 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡